Antiplatelet medications are widely used worldwide; however, their use can present challenges in patients who require invasive procedures with a high thromboembolic risk, such as neuroendovascular ...

Randomized trials of platelet function and genetic testing to guide antiplatelet decisions following PCI have produced notoriously mixed results: now, an updated consensus document aims to fill some ...

Antiplatelet drugs are one of the main tools used to prevent thrombus formation in people who have had a heart attack or ...

A new study created a score to identify patients with platelet hyperreactivity and risk of related, future cardiovascular disease. Platelets are circulating cell fragments known to clump up and form ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...